Protalix BioTherapeutics (PLX) Gross Profit (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 557.85% |
| Dec 31, 2025 | -52.73% |
| Sep 30, 2025 | -2.67% |
| Jun 30, 2025 | 406.36% |
| Mar 31, 2025 | -86.51% |
| Dec 31, 2024 | 49.54% |
| Sep 30, 2024 | 138.53% |
| Jun 30, 2024 | 250.61% |
| Mar 31, 2024 | -29.69% |
| Dec 31, 2023 | -70.10% |
| Sep 30, 2023 | -81.15% |
| Jun 30, 2023 | 344.83% |
| Mar 31, 2023 | 4.55% |
| Dec 31, 2022 | -12.51% |
| Sep 30, 2022 | 52.36% |
| Jun 30, 2022 | -53.58% |
| Mar 31, 2022 | 86.10% |
| Dec 31, 2021 | -35.33% |
| Sep 30, 2021 | 392.98% |
| Jun 30, 2021 | -74.16% |
| Mar 31, 2021 | -60.85% |
| Dec 31, 2020 | 111.35% |
| Sep 30, 2020 | -13.33% |
| Jun 30, 2020 | -49.84% |
| Mar 31, 2020 | 65.20% |
| Dec 31, 2019 | -0.13% |
| Sep 30, 2019 | 15.61% |
| Jun 30, 2019 | 13.80% |
| Mar 31, 2019 | 1,708.05% |
| Dec 31, 2018 | 58.37% |
| Sep 30, 2018 | -608.47% |
| Jun 30, 2018 | -110.87% |
| Mar 31, 2018 | 78.03% |
| Dec 31, 2017 | -37.33% |
| Sep 30, 2017 | 74.85% |
| Jun 30, 2017 | 4.24% |
| Mar 31, 2017 | 520.93% |
| Dec 31, 2016 | -69.43% |
| Sep 30, 2016 | 348.94% |
| Jun 30, 2016 | -39.74% |
| Sep 30, 2015 | 0.18% |
| Jun 30, 2015 | -21.21% |
| Mar 31, 2014 | 150.81% |
| Dec 31, 2013 | -467.66% |
| Sep 30, 2013 | 1.49% |
| Jun 30, 2013 | -41.74% |
| Mar 31, 2013 | 365.22% |
| Dec 31, 2012 | -137.38% |
| Sep 30, 2012 | -86.25% |
| Jun 30, 2012 | 812.75% |
| Mar 31, 2012 | 719.05% |
| Dec 31, 2011 | -56.57% |
| Sep 30, 2011 | 114.25% |
| Jun 30, 2011 | -190.96% |
| Mar 31, 2011 | 59.11% |
| Dec 31, 2010 | 54.88% |
| Sep 30, 2010 | 245.68% |